Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Health Communication in Families

NCT00597961

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Dovitinib in Neuroendocrine Tumors

NCT01635907

Conditions: Advanced Metastatic Paraganglioma, Advanced Metastatic Pheochromocytoma, Neoplasms, +11 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The Incidence of Breast and Other Cancers Among Female Flight Attendants

NCT00342407

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations: National Institute for Occupational Safety and Health (NIOSH) Cincinnati, Ohio, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

NCT00005971

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada

Lethbridge Cancer Clinic Lethbridge, Alberta, Canada

Penticton Regional Hospital Penticton, British Columbia, Canada

Prostate Centre at Vancouver General Hospital Vancouver, British Columbia, Canada

View all 50 locations

View Trial Details

Completed

Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma

NCT01103635

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

NCT00454363

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +44 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)

NCT02180061

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

NCT00118313

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02101918

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +22 more
Locations: Moffitt Cancer Center-International Plaza Tampa, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vemurafenib and TIL Therapy for Metastatic Melanoma

NCT02354690

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions